I have been working at the VA Medical Center and in the Department of Behavioral Neuroscience at the Oregon Health & Science University in Portland since 1979. I entered graduate school at the University of Colorado to obtain a Ph.D. in social psychology. Fortuitously, I was sidetracked into instead studying behavioral neuroscience (AKA biopsychology) at the fledgling Institute for Behavioral Genetics in Boulder. I’ve been pretty much surrounded by mice ever since. I did post-doctoral work at the University of Wisconsin- Milwaukee and was a Lecturer in Psychology at San José State and then UC-Santa Barbara, and then held a two-year research position at a Dutch pharmaceutical company in the Dutch hinterlands before Portland. My research interest is in understanding individual differences in behavioral susceptibility to alcohol and other drugs of abuse, and their genetic and neurobiological bases. Most recently, I’ve been breeding mice that voluntarily drink alcohol until they become intoxicated, i.e. developing a mouse model of university students. I’m working with collaborators to figure out how many genes we’ve affected in the process, which ones they are, and what their biological functions are. We’re using that information to try to predict some drugs that are already FDA approved that might be re-purposed to try as treatments for alcoholism. My expertise is in mouse behavioral tests that try to capture human traits such as anxiety, sensitivity to drug’s rewarding or aversive effects, incoordination, learning and memory, novelty-seeking, and so forth. I am less fluent in rat than in mouse but the languages are related. I am familiar with psychiatric genetics/human genetics methods, but not really expert in the more esoteric of them. I am also familiar with the big data/genomics/informatics approaches, but again not really expert there, either.
Dr. Crotty received his B.S. in Biology from the Massachusetts Institute of Technology (MIT) in 1996. He also received a B.S. in Writing from MIT the same year. Dr. Crotty undertook graduate work in virology at the University of California, San Francisco in the Program in Biological Sciences. There he discovered the mechanism of action of the antiviral drug ribavirin, widely used to treat chronic hepatitis C infections. Dr. Crotty earned his Ph.D. in Biochemistry and Molecular Biology in 2001. He then pursued postdoctoral work at the Emory University Vaccine Center with Dr. Rafi Ahmed from 2001 to 2003, studying aspects of the generation and maintenance of immune memory after viral infections. In 2003, he accepted a faculty position at LJI. The Crotty lab has helped established that follicular helper T cells (Tfh) are a distinct type of differentiated CD4 T cell uniquely specialized in B cell help, and that Tfh differentiation is controlled by the transcription factor Bcl6 (Science 2009). He has made major advances in the area of T cell help to B cells, and through this work has become an internationally recognized leader in the field of Tfh cell biology (Annual Review of Immunology 2011). Dr. Crotty was named a Pew Scholar in Biomedical Sciences in 2005, and was the recipient of the annualAmerican Association of Immunologists (AAI) Investigator Award for outstanding early-career research contributions to the field of Immunology in 2012. Dr. Crotty is also the author of Ahead of the Curve, a biography of Nobel laureate scientist David Baltimore, published in 2001, and reviewed in The Wall Street Journal, Nature, The Washington Post, The Journal of the American Medical Association (JAMA), Nature Medicine, and Discover Magazine.
Physician-in-Chief Emerita; Director, Autoimmunity and Inflammation Research ProgramHospital for Special Surgery
Lupus and APS Center of Excellence, Inflammatory Arthritis Center, Rheumatology, Rheumatoid Arthritis, Autoimmune Diseases, Lupus, Systemic Lupus Erythematosus (SLE), immune system activation
Dr. Mary Crow, a rheumatologist, is physician-in-chief emerita at Hospital for Special Surgery and a professor of Medicine in the Division of Rheumatology of the Department of Medicine at Weill Cornell Medical College. She is also director of the Autoimmunity and Inflammation Research Program at HSS and co-director of the Mary Kirkland Center for Lupus Research at the HSS Research Institute. Dr. Crow holds the Benjamin M. Rosen Chair in Immunology and Inflammation Research at HSS. She led the HSS Department of Medicine and the Division of Rheumatology in the Department of Medicine at Weill Cornell from 2010 to 2020. Dr. Crow’s academic and research career has focused on unraveling the cellular and molecular mechanisms that underlie the systemic autoimmune diseases, with a particular focus on systemic lupus erythematosus and rheumatoid arthritis. She has identified interferon-alpha, an immune system protein typically expressed in the setting of virus infection, as a key pathogenic mediator in lupus. Her laboratory continues to study the triggers of immune system activation in SLE, the molecular pathways associated with the clinical manifestations of lupus, and the mechanisms that result in disease flares. Dr. Crow’s research has identified therapeutic targets, providing the rationale for the development of novel therapeutic agents for patients with SLE. In addition to her leadership roles at HSS and WCMC/NYPH, Dr. Crow has served as president of the American College of Rheumatology, as president of the Henry Kunkel Society, and as chair or co-chair of the Scientific Advisory Board of the Alliance for Lupus Research and the Lupus Research Alliance from 2008 to 2019. She has been honored as an “Arthritis Hero” of the Arthritis Foundation, and in 2010 she received the Margaret D. Smith Lifetime Achievement Award of the Arthritis Foundation, New York Chapter. In 2018 she received the Presidential Gold Medal of the American College of Rheumatology, and in 2019 she was honored as a Notable Woman in Healthcare by Crain’s New York Business.
The National SEED Project (Seeking Educational Equity and Diversity) partners with schools, organizations, and communities to develop leaders who guide their peers in conversational communities to drive personal, organizational, and societal change toward social justice. As co-director of the National SEED Project, Gail Cruise-Roberson supports New York City-area educators and community leaders who run their own year-long, school-based SEED seminars in order to drive social change. Throughout her career, Cruise-Roberson has worked in public education reform and adult education in New York City, Newark, NJ, and Chicago, Il. In 1999, Cruise-Roberson began working to train diversity facilitators -- teachers as well as high school students and parents -- to lead their own year-long seminars with the Minnesota Inclusiveness Project. In 2008, she joined the staff at the National SEED Project and co-facilitated SEED seminars in California. She has a B.A. in English and graduate work in communications from Queens College (CUNY), with a focus on small group communication.
Dr. Crutchfield, a nationally known expert on concussions and traumatic brain injury, directs LifeBridge Health’s Comprehensive Sports Concussion Program. He has served as an independent neurologist for many professional sports leagues and is board certified in psychiatry and neurology. He is a faculty appointee at the Uniformed Services University of Health Sciences and is a researcher and consultant to the U.S. military regarding the effects of traumatic brain injuries.
Director, Center for Health Services Research Board of Governors Professor, School of Social WorkInstitute for Health, Health Care Policy and Aging Research at Rutgers University
Opioids, Children's Mental Health, long-term care, Nursing Homes, substance abuse treatment, Mental Health Medications
Stephen Crystal (Ph. D., Harvard, 1981) is a Research Professor and Chair of the AIDS Policy Research Group at the Institute. He directs the Center for Health Services Research, focusing on pharmacotherapy, chronic disease management, and outcomes, as well as the Center for Health Services Research Development, funded under a grant from the Agency for Healthcare Policy and Research and Quality (AHRQ). Dr. Crystal also serves as Associate Director for Research of the Center for State Health Policy. Dr. Crystal’s research group conducts a variety of studies addressing use, access, costs and outcomes of health care services, as well as research on policies and programs affecting the elderly. The group has published extensively on HIV treatment and on health care for the elderly. A growing area of the group’s work in recent years has focused prescription drug use, management, outcomes and policies. The research group has developed and utilized a number of large and rich research databases to support research in all of these critical areas. Dr. Crystal’s work over the years in both academic and non-academic settings has addressed a range of key issues in state and local health policy; he has worked extensively on the delivery of health care services through state Medicaid programs. His research and publications in the aging area include work on economic well-being of the elderly; long-term care of older people; insurance status and the impact of out-of-pocket health care costs; Medicare policy; and pharmaceutical drug policies for lower income elderly. He heads a team of investigators addressing HIV health services delivery issues. His research group has developed the capacity to carry out detailed studies of Medicaid health care utilization and outcomes using claims and other administrative files and has applied this expertise to a series of studies funded by the Agency for Health Care Policy and Research and Quality (AHRQ), the National Institute of Drug Abuse, the National Institute of Mental Health (NIMH), the National Institute on Aging, HHS’s Assistant Secretary for Planning and Evaluation, the Commonwealth Fund, and other agencies and foundations. He currently heads an NIMH-funded national study of treatment for geriatric depression. His more than 200 publications include books on old-age policy and on home health care, and research articles, reviews and technical reports addressing a wide range of issues in old-age policy, health services research, long-term care for the elderly, pharmaceutical use, mental health services, and other topics related to healthcare and aging. He is a frequent advisor to federal, state and international health agencies and has served on numerous study sections and peer reviews. He has served as Visiting Professor of Health Care Policy at Harvard Medical School’s Department of Health Care Policy and as Chief of the Division of Health Care Sciences at the School of Medicine, University of California, San Diego. During the late 1970s and early 1980s, he held a variety of senior positions in health services delivery in New York City government, managing major health and human services programs, and created and headed the Center for Human Services Research and Development, which conducted national studies in areas including home care and adult protective services. He has also served as an Urban Fellow in New York City’s Office of the Mayor, and consultant at the City’s Office of Management and Budget. His awards include the Abt Associates Prize for Public Policy Research and the John Kendrick Award for research on the economic status of the elderly.
As the founding executive director of UCI’s multidisciplinary Cybersecurity Policy & Research Institute, Bryan Cunningham is focused on solution-oriented strategies that address technical, legal and policy challenges to combat cyber threats; protect individual privacy and civil liberties; maintain public safety, economic and national security; and empower Americans to take better control of their digital security. Cunningham is a leading international expert on cybersecurity law and policy, a former White House lawyer and adviser and a media commentator on cybersecurity, technology and surveillance issues. He has appeared on ABC, Bloomberg, CBS, CNN, FOX and other networks. Cunningham has extensive experience in senior U.S. government intelligence and law enforcement positions. He served as Deputy Legal Adviser to then-National Security Advisor Condoleezza Rice. He also served six years in the Clinton administration as a senior CIA officer and federal prosecutor. He drafted significant portions of the Homeland Security Act and related legislation, helping to shepherd them through Congress. He was a principal contributor to the first National Strategy to Secure Cyberspace, worked closely with the 9/11 Commission and provided legal advice to the President, National Security Advisor, the National Security Council, and other senior government officials on intelligence, terrorism, cyber security and other related matters. Cunningham is a founding partner of the Washington, DC-Los Angeles firm Cunningham Levy Muse, and his law practice has included assisting Fortune 500 and multinational companies to comply with complex legal regulations under U.S. federal law, myriad state laws and the numerous privacy and security requirements in the European Union and other overseas jurisdictions. He was founding vice-chair of the American Bar Association Cyber Security Privacy Task Force and was awarded the National Intelligence Medal of Achievement for his work on information issues. He has served on the National Academy of Sciences Committee on Biodefense Analysis, the Markle Foundation Task Force on National Security in the Information Age and the Bipartisan Policy Center’s Cyber Security Task Force. He is also the principal author of legal and ethics chapters in several cybersecurity textbooks.
Kirk is an internationally renowned expert in bioimaging with 30 years’ experience and over 100 publications. He is proud of his role in discovering a new imaging approach to follow subcellular calcium signaling in filamentous fungi—a world first. His research today focuses on small microbes that cause disease in both humans and plants. And he is dedicated to his role at the Danforth Center, partnering with numerous colleagues to help advance their research as well. In 2019, Kirk joined the Donald Danforth Plant Science Center as a principal investigator and director of the Advanced Bioimaging Laboratory Facility, to leverage advanced microscopy tools in plant science dedicated to producing more nutritious food and improving the environment. With over 30 years of advanced microscopy experience, Dr. Czymmek has expertise in most forms of light, X-ray, and electron microscopy, atomic force microscopy, single-molecule imaging, superresolution microscopy, cryotechniques, and correlative microscopy. His work on developing and applying cutting-edge microscopy tools for imaging cells, tissues, and biomaterials has generated over 95 refereed publications. Prior to joining the Danforth Center, Kirk served as Vice President of Global ZEISS Microscopy Customer Centers and oversight of eight customer centers and their teams worldwide. He joined the company in 2012 to build a world-class application, demonstration, and training center for the ZEISS microscopy portfolio for North America. From 2000 to 2012 he was an Associate Professor in the Department of Biological Sciences at the University of Delaware (UD) where he worked to build an imaging capacity that led in 2001 to the creation of the UD Bio-Imaging Center at the Delaware Biotechnology Institute, where he served as Director. Kirk received his doctorate in the Department of Botany and Plant Pathology at Michigan State University in 1993 followed by a post-doctoral position at the DuPont Company in CR&D Plant Molecular Genetics group. Subsequently, he worked with Noran Instruments in the confocal business group as an applications scientist before joining the University of Delaware. He has received many awards and honors for his achievements in the field.
Diana D’Amico Pawlewicz, Ph.D., a historian of education and social policy, is an assistant professor in the Educational Foundations and Research Program at the University of North Dakota supported by the Elnora Danley Professorship. Dr. D’Amico Pawlewicz’s research explores school policy as social policy and centers on fundamental questions around equity, race, power, and the role of institutions in creating or disrupting inequality. Dr. D’Amico Pawlewicz strives to construct her historical scholarship upon an interdisciplinary foundation that draws upon sociology, economics, gender studies, and critical race theory. Through her scholarship and teaching, Dr. D’Amico Pawlewicz envisions herself as a bridge builder connecting (1) history to disciplines across the university, (2) the past to the present, and (3) the university to the public. Specifically, Dr. D’Amico Pawlewicz’s research explores the history of the public school workforce and the creation and maintenance of racialized ideas, policies, and practices. Her work has appeared in the Washington Post, History of Education Quarterly, Harvard Educational Review, Labor: Studies in Working Class History, American Educational Research Journal, and several other outlets. Dr. D’Amico Pawlewicz’s first book, Blaming Teachers: Professionalization Policies and the Failure of Reform in American History, will be out in August of 2020. She is also editing a volume entitled Walkout: Teacher Militancy, Activism, and School Reform to be published by IAP and conducting research for her third book, tentatively titled Pathologizing Blackness: The National Teacher Corps, Federal Education Policy, and the Politics of Race and Achievement. Dr. D’Amico Pawlewicz earned her Ph.D. from New York University where she was a Spencer Dissertation Fellow and received the Politics of Education Association’s Outstanding Dissertation Award. After earning her degree, she spent a post-doctoral year as a visiting assistant professor at Brown University. Before arriving at UND, Dr. D’Amico Pawlewicz was assistant professor at George Mason University where she served as Professor-in-Charge of the Education Policy Doctoral Specialization and was named a University Teacher of Distinction.
Dr. Daadi is an expert in regulated translational research and has developed therapeutic neural stem cell lines (NSC) for clinical use in Parkinson’s disease, stroke, and to target brain tumors in both industrial and academic settings. He discovered a novel technique of engineering these stem cell lines from pluripotent human embryonic stem cells and continues to develop this therapeutic cell line for clinical use. Dr. Daadi came to Texas Biomed in 2014 and is the team leader for the SNPRC Regenerative Medicine and Aging research unit. Results from his studies are the foundation of translational research and help to repair diseased or injured brain through transplantation of highly purified NSCs and stimulation of internal repair mechanisms.
Jamshid Damooei, Ph.D. is a professor and the director of the undergraduate economics program and executive director of the Center for Economics of Social Issues (CESI) at California Lutheran University. Prior to joining the Cal Lutheran faculty, Damooei served as a senior economist for the United Nations Development Program (UNDP). In the early 1980s, he was the director general of the Department of Economic Studies and Policies of the Ministry of Economic Affairs and Finance of Iran. During the last 25 years, he has become more focused on the economic analyses of social issues. He has published in professional and popular journals and edited books on the subject. His research endeavors on the topic of investing in children resulted in publication of multiple pioneering studies on the economic impact of the Boys & Girls Clubs of America in a number of states and metropolitan areas. In all of his recent studies on children, there is a strong emphasis on the impact of socioeconomic status of children on their academic performance, social behavior and opportunity to be successful in their lives as they grow up. Damooei received the President’s Award for Teaching Excellence from California Lutheran University in 2006 and the Provost Distinguished Scholar Award for the 2017-2018 academic year. The Huffington Post recognized him in 2017 as one of the Iranian-Americans who have made seminal contributions to their fields of endeavor. He has served as a consultant for many organizations including Boys & Girls Clubs across various states, First 5, United Way, Blue Cross, Blue Shield, public health entities and various foundations within Ventura and Los Angeles counties. He recently completed three major studies for the Ventura County Community Foundation. Damooei’s other scholarly work includes a broad spectrum of current social and economic issues such as: project design and evaluation, methods of capacity-building during time of crisis, crisis prevention and recovery, causes of economic imbalance, aid coordination, privatization of industries, financial problems, and economic and social-impact assessments of policies and institutions. He writes op-eds for a regional newspapers and is often interviewed by various news media. His views and commentaries on international economic issues are frequently sought by international media, including the BBC. While Damooei worked at UNDP and later as an international consultant with UNDP and the United Nations Office of Project Services, he conducted a number of studies on the economic issues of Somalia and the Horn of Africa. His studies relate to the political instability and economic crises facing the area.
Nicholas Davis is Head of Society and Innovation and a member of the Executive Committee at the World Economic Forum in Geneva, Switzerland. Nick leads the Forum’s work on “The Fourth Industrial Revolution”, focusing on how emerging technologies could disrupt industries, labour markets, societies and governments, and how technology can be used to empower communities to create a human-centred future. Nick also oversees a range of projects and expert groups focused on entrepreneurial ecosystems, and is responsible for the Forum’s global NGO, labour and faith communities. Nicholas Davis is currently a Professor of Practice at Thunderbird School of Global Management. Previously a commercial lawyer in Australia, Director at Oxford Investment Research and the World Economic Forum’s Head of Europe, Nick is a Certified Professional Facilitator and a Fellow of the Royal Society of the Arts (FRSA) in the UK. He sits on the board of the IMP3rove European Innovation Management Academy and holds degrees in Arts and Law from the University of Sydney as well as a Masters of Business Administration from the University of Oxford.
Professor of Psychology Research Professor at the Institute for Social Research Associate Director of the Michigan Institute for Data ScienceUniversity of Michigan
Social Work and Psychology, Education and Psychology, Cognition, Psychology, Developmental Psychology, Quantitative Methods, Family
Dr. Davis-Kean is a Professor of Psychology at the University of Michigan where her research focuses on the various pathways that the socio-economic status (SES) of parents relates to the cognitive/achievement outcomes (particularly mathematics) of their children. Her primary focus is on parental educational attainment and how it can influence the development of the home environment throughout childhood, adolescence, and the transition to adulthood. Davis-Kean is also a Research Professor at the Institute for Social Research where she is the Program Director of the Population, Neurodevelopment, and Genetics (PNG) program. This collaboration examines the complex transactions of brain, biology, and behavior as children and families develop across time. She is interested in how both the micro (brain and biology) and macro (family and socioeconomic conditions) aspects of development relate to cognitive changes in children across the lifespan.
Associate Professor of Law; Director, Community Economic Development ClinicAlbany Law School
Economic Development, Housing Law, Housing Policy, access to justice, Business Law, Clinical Legal Education, Class and Economic Inequality, Poverty Law, Government Law and Policy
Professor Edward W. De Barbieri teaches courses in community economic development law and directs the Community Economic Development Clinic, which focuses on community-based transactional skills and advocacy. His scholarship examines ways the public can engage in land use approvals and economic development activities and how that engagement can lead to reforms in economic and social systems. His articles have appeared or are forthcoming in the Fordham Law Review, Florida State University Law Review, Cardozo Law Review, Fordham Urban Law Journal, and Journal of Affordable Housing & Community Development Law. Prior to joining the Albany Law School faculty in 2016, Professor De Barbieri directed a community economic development clinic at Brooklyn Law School, and was an Adjunct Professor of Clinical Law at New York University School of Law. His background also includes work as a legal services attorney at the Community Development Project of the Urban Justice Center, beginning as an Equal Justice Works fellow. He spent his final year of law school conducting research in Ireland as a Fulbright fellow, and is a graduate of Yale Divinity School, where he concentrated in religious ethics. LL.M. National University of Ireland, Cork, MAR Yale Divinity School, J.D. Brooklyn Law School
Lisa Delpy Neirotti is the director of the MS in Sport Management Program and an associate professor of Sport Management at the George Washington University School of Business (GWSB). She has been a professor of sport, event, and tourism management at the George Washington University for more than 28 years. Dr. Delpy Neirotti has established a strong academic program at both the undergraduate and graduate level and has also helped develop the Sport Philanthropy Certificate, which serves to increase the efficiency and effectiveness of non-profit organizations using sport for social good. She also directs the GW Green Sports Scorecard to help increase the sustainability of sport facilities, organizations and events, and serves on the faculty of the International Olympic Committee’s Executive Master's In Management of Sports Organizations (MEMOS). Beyond her responsibilities at GW, Dr. Delpy Neirotti works with a number of sport event organizations, sponsors, and professional teams to conduct economic and market research studies including the Olympic Games, World Cup, BNP Paribas Open, Citi Bank Tennis Tournament, Rock and Roll Marathon, Marine Corp Marathon, College Football Bowl Games, among others. As a pioneer in the field of sports tourism, Dr. Delpy Neirotti founded the annual TEAMS: Travel, Events, and Management in Sports conference. Since 1997, TEAMS serves to define, develop and expand the fast growing field of Sports Tourism. Numerous organizations including USAID have commissioned her to look at sport tourism as an economic development tool. Dr. Delpy Neirotti co-authored The Ultimate Guide to Sport Event Management and Marketing and serves on the editorial board of SportsTravel magazine. She also is a member of the Women’s Sport Foundation (WSF), Up2Us, and Council for Responsible Sports advisory boards as well as Vice-President of the DC Chapter of Women In Sports and Events (WISE). Prior to arriving at the George Washington University, Dr. Delpy Neirotti traveled to 56 countries around the world studying the development and organization of the Olympic Movement. Since 1984, she has attended 19 consecutive Olympic Games, 5 World Cups, and hundreds of other major sport events as a consultant, volunteer or researcher. In 2004, she served on the World Cup host committee in Washington, DC. Born and raised in California, Dr. Delpy Neirotti received her undergraduate degree from California Polytechnic State University, San Luis Obispo; a MS in Sport Management from George Mason University, Fairfax, VA; and a Ph.D. in Sport Administration from the University of New Mexico in Albuquerque. Her doctoral dissertation was on the organizational structure and effectiveness of the U.S. national sport governing bodies.
Christopher Dennison, PhD, is an assistant professor in the UB Department of Sociology. Most broadly, his research examines the association between intergenerational social mobility and changes in antisocial behavior across the life course. Other research interests include individual and “spillover” effects associated with involvement in the criminal justice system. His most recent project examines risky behavior among first- and continue-generation college students and how this relates to graduation. Education: PhD, Bowling Green State University, 2017 MA, University of Toledo, 2013 BA, Miami University, 2011
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory Medicine and Pediatrics, Associate Professor of Preventive Medicine and Community Health and Assistant Dean for Research in Health Policy at the New Jersey Medical School, Newark, New Jersey. He has served on numerous committees for the NIH over the last two decades and currently is the principal investigator of an NIH portfolio in excess of 56 million dollars. Mr. Denny was a 2002-2003 Robert Wood Johnson Foundation Health Policy Fellow at the Institute of Medicine of the National Academies (IOM). As a fellow, he served on the US Senate Health, Education, Labor and Pensions Committee with legislation/policy responsibilities in global AIDS, bioterrorism, clinical trials/human subject protection and vaccine related-issues.
Associate Professor, Department of Biomedical Sciences, University of North Dakota, School of Medicine and Health SciencesNorth Dakota Established Program to Stimulate Competitive Research (ND EPSCoR)
Dr. Dhasarathy did her PhD at Texas A&M University and postdoctoral training at the NIH. She joined the University of North Dakota in 2012. She is a molecular biologist whose research focuses on the role of epigenetic events in cancer metastasis, and particularly, a process known as ‘Epithelial to Mesenchymal Transition’ (EMT), which causes cells to change their shape and migrate. She is studying how DNA, RNA and protein interact to change and regulate gene expression, which is the underlying cause of both normal and disease states. She is an ND-ACES Cellular Systems at Materials Interface Pillar Co-lead. ND-ACES: New Discoveries in the Advanced Interface of Computation, Engineering, and Science (ND-ACES), North Dakota EPSCoR’s most recent NSF cooperative agreement, is a five-year cooperative agreement that carries an 80/20% federal/state match. 2020-2025 NSF EPSCoR Track-1 Cooperative Agreement, $20 million, Award Number 1946202.
Dr. Rosa Diaz is the Missions Engineering and Science Analysis Branch Deputy supporting, coordinating, or managing several cross-instrument and cross-mission projects for the Hubble Space Telescope, James Webb Space Telescope, and Nancy Roman Space Telescope. She works with teams and technical leads on projects that range from the design, implementation, and maintenance of software and systems to the testing and validation of scientific algorithms and documentation for missions. Dr. Diaz also participates in public outreach efforts, particularly focusing on reaching out to the Latin American community.
Teresa P. Diaz-Montes, M.D., MPH, FACOG, serves as the Associate Director of The Lya Segall Ovarian Cancer Institute. She also is a noted expert and gynecologic oncologist with The Gynecologic Oncology Center at Mercy, a leading Center in Baltimore for the treatment of cancers of the female reproductive tract. Dr. Teresa Diaz-Montes provides diagnosis and treatment for gynecologic cancers including ovarian cancer, cervical cancer, uterine cancer, vaginal cancer, and vulvar cancer. Board Certified in Gynecologic Oncology, Dr. Teresa Diaz-Montes provides treatment for a diverse range of gynecologic cancers. Her primary clinical interests include ovarian cancer treatments, minimally invasive gynecologic surgery, including robotic surgery, and patient safety and quality. Additional areas of interest include cervical cancer, fallopian tube cancer, fertility-sparing surgery and uterine, vaginal and vulvar cancers. Bringing a friendly approach to the treatment of her patients, Dr. Diaz-Montes takes the necessary time to listen to the needs of her patients and address their concerns. As a recipient of the Patient's Choice award, her approachable, caring bedside manner has been formally recognized by her patients. Dr. Teresa Diaz-Montes is known for her knowledge and dedication to finding advanced treatments for gynecologic cancers. Her expert opinion is often sought by media outlets and she has been featured in notable publications such as The Wall Street Journal and The New York Times. She was also featured by The Sun Magazine as "One of 50 Women to Watch" for her dedication to innovative treatments for ovarian cancer. Dr. Diaz-Montes has extensive experience in research and resident teaching activities. She has conducted various clinical trials to advance the care of gynecologic cancers, particularly ovarian cancer. She and colleagues in The Institute for Cancer Care at Mercy are conducting the first clinical study in the United States regarding the treatment of ovarian cancer with hyperthermic intraperitoneal chemotherapy, also known as HIPEC. Dr. Diaz-Montes, an author and international lecturer, has numerous clinical publications related to women’s cancer treatment to her credit. Awards and Honors Top Doctor in Gynecologic Oncology, Baltimore magazine Top Doctor in Gynecologic Oncology, Castle Connolly Medical Ltd.